Zobrazeno 1 - 10
of 549
pro vyhledávání: '"Bilastine"'
Publikováno v:
Indian Journal of Dermatology, Vol 69, Iss 3, Pp 226-231 (2024)
Introduction: Chronic spontaneous urticaria (CSU) is the most commonly diagnosed skin condition in dermatology outpatient departments. Second-generation antihistamines are shown to be effective in the control of CSU. As per the guidelines, a combinat
Externí odkaz:
https://doaj.org/article/754d6dcfa2154337a4d130203d387f8c
Autor:
Atsushi Fukunaga, Yasumasa Kakei, Sae Murakami, Yuji Kan, Koji Masuda, Masatoshi Jinnin, Ken Washio, Hiroo Amano, Tohru Nagano, Akihisa Yamamoto, Toshihiro Otsuka, Shunsuke Takahagi, Motoi Takenaka, Naoko Ishiguro, Koremasa Hayama, Naoko Inomata, Yukinobu Nakagawa, Akiko Sugiyama, Michihiro Hide
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundFor treating patients with refractory chronic spontaneous urticaria (CSU) resistant to standard doses of 2nd generation H1-antihistamines (H1AH) the International and Japanese guidelines recommend increasing H1AH dose. The latter also recom
Externí odkaz:
https://doaj.org/article/bd24e6bf28374599bec1ab1ebacc63e9
Autor:
Giorgio Walter Canonica, Piotr Kuna, Marcus Maurer, Ralph Mösges, Zoltan Novak, Nikolaus Papadopoulos, Pablo Rodriguez del Rio, the Delphi Study Group
Publikováno v:
Drugs in Context, Vol 13, Pp 1-10 (2024)
Background: Second-generation oral H1-antihistamines, including bilastine, represent the emerging treatments of allergic rhinitis (including rhinoconjunctivitis) and chronic urticaria in both adults and children. This study analyses available evidenc
Externí odkaz:
https://doaj.org/article/ae0f855dbf244fa9950fe78f720e7985
Publikováno v:
Indian Journal of Dermatology, Vol 69, Iss 2, Pp 132-136 (2024)
Introduction: The treatment options for chronic spontaneous urticaria (CSU) primarily include second generation non-sedative antihistamine (SGAHs). Bilastine is a newer, nonsedating SGAH approved for urticaria in February 2019 by the Drugs Controller
Externí odkaz:
https://doaj.org/article/0b924d82011a4cf5b54667d035673436
Publikováno v:
BMC Chemistry, Vol 18, Iss 1, Pp 1-13 (2024)
Abstract For the treatment of rhinitis and asthma, a combination of Montelukast sodium and Bilastine has just been approved. Based on the first derivative of synchronous fluorescence, the current work developed a green, highly accurate, sensitive, an
Externí odkaz:
https://doaj.org/article/a899faacad554b8fb4863bc21976c92c
Publikováno v:
BMC Chemistry, Vol 17, Iss 1, Pp 1-23 (2023)
Abstract For the simultaneous estimation of two co-formulated antihistaminic drugs (Bilastine and Montelukast), a novel and eco-friendly reversed-phase HPLC approach with both diode array and fluorescence detection modes was designed. Rather than usi
Externí odkaz:
https://doaj.org/article/3e1b63e937884102b2ae90da4fbf75fd
Publikováno v:
Clinical Ophthalmology, Vol Volume 17, Pp 735-746 (2023)
Piotr Kuna,1 Marek Jutel,2,3 Grazyna Pulka,4 Slawomir Tokarski,5 Paula Arranz,6 Gonzalo Hernández,6 Nieves Fernández Hernando6 1Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland; 2Department of Clinical I
Externí odkaz:
https://doaj.org/article/650e0621d79642918195951c11adb5b9
Design, Optimization and Characterization of Self-Nanoemulsifying Drug Delivery Systems of Bilastine
Publikováno v:
Iraqi Journal of Pharmaceutical Sciences, Vol 32, Iss Suppl. (2023)
Self-nanoemulsifying drug delivery systems are innovative methods that have the potential to resolve a variety of drug formulation issues, including solubility, stability and bioavailability. Bilastine is a potent and highly selective H1-antihistamin
Externí odkaz:
https://doaj.org/article/fff8852f1bde45dba5e580789ef1c013
Autor:
Vishakha V Sinha, Mrunalini Vinay Kalikar, Jayesh Ishwardas Mukhi, Akhil Bhagwan Giradkar, Smita Sontakke
Publikováno v:
Perspectives in Clinical Research, Vol 14, Iss 4, Pp 180-186 (2023)
Purpose: Bilastine is a novel second-generation antihistaminic. Very few studies in Indian population have compared the safety and efficacy of bilastine with other second-generation antihistaminic like cetirizine. Hence, the present study was planned
Externí odkaz:
https://doaj.org/article/92fa1cc8e3d94e38808ece602cb511c1
Autor:
Wai Kwong Cheong, Alson Wai Ming Chan, Chin Chwen Ch’ng, Wen Hung Chung, Ma Teresita Gabriel, Kiran Godse, Wat Mitthamsiri, Hao Trong Nguyen, Marysia Tiongco-Recto, Dinesh Nagrale
Publikováno v:
Drugs in Context, Vol 11, Pp 1-11 (2022)
Urticaria is a disabling condition, resulting in an impaired quality of life and sleep disruption, and can have an adverse impact on work-related or school-related performance and attendance. It is defined according to the presence of unknown (chroni
Externí odkaz:
https://doaj.org/article/77ad8c328a494fe7bd26e783c9f393ce